Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells - Wikidata - awgldk - TriplyDB

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

http://www.wikidata.org/entity/Q36403419

about

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2 Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm Immune regulation of human herpesviruses and its implications for human transplantation Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician Flow cytometry and solid organ transplantation: a perfect match Cell-mediated immunity to human CMV infection: a brief overview Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations.CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects.NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease Controlling cytomegalovirus: helping the immune system take the lead Cytomegalovirus infection- and age-dependent changes in human CD8+ T-cell cytokine expression patterns Cytomegalovirus infection in pediatric rheumatic diseases: a review.Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft Systems vaccinology.An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells.Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis.Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.Blood dendritic cell levels associated with impaired IL-12 production and T-cell deficiency in patients with kidney disease: implications for post-transplant viral infections.Whole CMV proteome pattern recognition analysis after HSCT identifies unique epitope targets associated with the CMV status.Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques.Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells.Immunological mechanisms of vaccination.Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

P2860

Q24657388-64F23344-15D2-4CCF-BD53-CAAF0B6BE63A Q24676067-81C5E448-8CFA-42E2-8C9F-0F10E735D6EC Q26740328-5AE54B93-493F-42CC-AF4C-B9855AA5165E Q26850340-D8DBEA34-2CED-4620-B45A-D865FD5E7229 Q26992146-78B32062-47D8-40CF-A584-F45F92BE29C6 Q26998832-89068029-7245-4594-8343-D18F0CD54D3B Q27014778-97FC7474-3132-45D0-9810-48D1ABE68E39 Q27026499-C24C9F69-374E-4391-94C2-502F406B44D5 Q27026981-07416636-835C-497E-B537-96D3950F9EB6 Q28072627-D3320511-B4D7-4F08-A3D1-3D37082BA79B Q30353821-EED4F9A3-2CF6-4987-B8DD-177088BE5F86 Q33260079-3C22DD5A-43A3-4A24-BDB7-9516C54AF85E Q33280303-2DAE9F5A-AA79-403D-802E-A34C3107F35F Q33340287-E2AF52A4-3135-4C0E-8433-D55EBA6747D1 Q33523611-E22D30E0-95D6-431B-87BA-5A2FA86CB118 Q33820695-838FF3C0-44BC-43CA-BECE-8E373C768A6A Q33909200-613C796B-D5A5-4431-B1CF-A2700E63B9F1 Q33912101-5C48887D-601E-480A-A531-2929B6DACE9F Q33932079-09DA45D9-117A-4891-BD21-DFFF72F33D8B Q34105900-1DC4DE36-AD4A-4AEC-84FB-371F94A7791A Q34402910-AFEB71A8-4F87-4917-A2F0-3AE6982FC0DC Q34448341-51CEC7C5-E33B-424A-BCCD-6648C0C5B0BE Q34524941-D32794E3-0C10-4E31-B7B9-28CD8BF2D133 Q34592551-7034146E-3803-47D4-AB9C-53186E4DBB78 Q34594928-AA832B25-BF47-4F5B-9A51-5547B99C6325 Q34605186-5C05AB7B-D0FD-4587-AED6-8A95E8085DE4 Q34720787-E50DAE1B-30A7-4903-BB6B-2542E52AFA08 Q34743762-E3BCAC09-D488-4160-9272-8BB1B24ED78F Q35124583-3AE9B2E9-0297-4EEC-8986-AC24933C35D0 Q35150820-434C9FB0-2661-4EC6-B44F-F8A73844A912 Q35150896-87FFBBAA-3C9E-4F2B-A71C-ACFB968250E4 Q35156297-439F065B-8B3E-4688-AF95-52535FD64998 Q35196400-FDD5BA30-0F93-41BB-A7C0-97A12CA9AD37 Q35233773-180A6DC3-FBBE-4E1C-8CB8-9A28FF4E73DF Q35463623-9C468E50-5E38-4E79-9B6E-CD678663F82C Q35644477-5013F9A1-0E6D-485A-8A22-07BF5D46F68B Q35659533-ED4DB1A8-30AB-4761-9A20-218DEFBADB93 Q35665881-E66CC973-0D9A-48CB-A397-6C9995DE1860 Q35751946-4D9A74CA-D616-4C7E-86E7-03DFCA6D025D Q35759682-2C257646-D7E1-4062-B071-5FD0E1F3B08C

P2860

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

http://www.wikidata.org/entity/Q36403419

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@ast

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@en

type

label

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@ast

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@en

prefLabel

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@ast

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@en

P1433

Q36403419-F534B339-13D0-4DE7-BA84-6D650C298A8F

P1476

Q36403419-8B925724-A7B2-41A4-9383-E7F3E92A895A

P2093

Q36403419-00F5DC0E-8209-4B68-974D-57D3990D653C

Q36403419-21B3779A-E813-43E9-B095-03C716A81470

Q36403419-287AF73A-0631-4F34-A118-13E2DB9E2B28

Q36403419-4CA10DC9-E964-452F-9ACC-56E325165FA4

Q36403419-9A289CCE-AC32-4BA5-B4C3-E671DED1A2CF

Q36403419-B2828AA5-9AB2-4FB0-92D9-425135686E11

Q36403419-D2B6844F-8BC8-4559-B627-5B586D261072

P2860

Q36403419-12593C6A-A5F7-48F9-8043-18946A605D00

Q36403419-1A11354D-3AB9-4397-890C-B091C5244512

Q36403419-25EDF2A7-08B8-4981-B4E3-98A64C3FE996

Q36403419-32121F6F-FE1D-4DB1-A451-65F8BFB4A78F

Q36403419-378E188F-5C58-461F-B70C-32DAA1BDEDF5

Q36403419-3B843DCD-2048-4C2F-94C0-EB7D6F164EBA

Q36403419-3B8F2243-DB34-4DD4-A7B7-C3EFB5207163

Q36403419-4C3B012F-2EFF-4978-A0BE-AFA2CE14E5F6

Q36403419-52444784-206A-4B05-BE64-9AC7F09927E9

Q36403419-5825EA45-F963-4EC2-9D09-83ADD2BBF379

P304

Q36403419-4BB19B3B-35B9-47F8-AE16-99104B201BDB

P31

Q36403419-E65134E2-6AEC-4686-8985-3A80A1E9D382

P356

Q36403419-4302616D-BE73-4AEB-8D6E-383F747AB83F

P407

Q36403419-72B87654-994A-409E-B6FE-D0128D6EE436

P433

Q36403419-BEF1A329-6E5A-4206-A27E-595D529FA998

P478

Q36403419-760EF749-D70B-496D-9297-953D4472367A

P50

Q36403419-9A10B838-E0C9-49B3-A433-1C238CA66765

Q36403419-C50AEE2F-5626-47C0-A0BA-EA14CD5D2EB5

Q36403419-F0D284DA-FBD6-4AB2-8F2E-4B106BD737B6

Q36403419-F6741D4B-6A3C-4A2D-B09B-B580CFC5C533

P577

Q36403419-6DBA5DA5-1152-4861-BDD7-7BB7168D5E7E

P5875

Q36403419-2A1A7710-9546-4ECA-AA40-995DE9FF8EFD

P698

Q36403419-DB562B89-8610-4DE6-86DC-80136C4A7823

P921

Q36403419-2C486CF9-5C68-4E39-B781-6CB45D0C859B

P932

Q36403419-C687A9E8-B6E3-4C14-B56F-0B97949D0271

P356

P1433

Journal of Experimental Medicine

P1476

Protection from cytomegaloviru ...... e early 1-specific CD8 T cells

@en

P2093

Alexander Kirchner

http://www.w3.org/2001/XMLSchema#string

Bodo Hoffmeister

http://www.w3.org/2001/XMLSchema#string

Dirk Habedank

http://www.w3.org/2001/XMLSchema#string

Hans Lehmkuhl

http://www.w3.org/2001/XMLSchema#string

Hans-Dieter Volk

http://www.w3.org/2001/XMLSchema#string

Susanna Proesch

http://www.w3.org/2001/XMLSchema#string

Torsten Bunde

http://www.w3.org/2001/XMLSchema#string

P2860

Flow cytometric enumeration of antigen-specific T lymphocytes.

Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

Principles for adoptive T cell therapy of human viral diseases.

Infection in organ-transplant recipients.

Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus.

Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.

Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides.

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.

P304

1031-1036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20042384

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

Georgy Cherepnev

P577

2005-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7941197

http://www.w3.org/2001/XMLSchema#string

P698

15795239

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

2213133

http://www.w3.org/2001/XMLSchema#string